A
Atossa Therapeutics, Inc. Common StockATOS
Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company developing innovative medicines in oncology and other areas of significant unmet need. The Company's lead product candidate, (Z)-endoxifen, is currently in development across several clinical.
US StocksHealthcareSmall CapBiotechnology
Xu hướng giá ATOS
Atossa Therapeutics, Inc. Common Stock · Biểu đồ TradingView đầy đủ
NASDAQ:ATOS